logo-loader
viewCello Health PLC

Director/PDMR Shareholding

/**/ ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue }visited{ color: purple } .bb{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.bb{}p.do{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Calibri","sans-serif";color:black;text-align:justify}span.dm{font-size:10.0pt; font-family:"Arial","sans-serif"}p.dp{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Calibri","sans-serif";color:black;font-weight: bold; text-align: center}span.dk{font-size:10.0pt;font-family:"Arial","sans-serif"}p.dq{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Calibri","sans-serif";color:black;margin-bottom: 12.0pt; text-align: center}p.dr{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Calibri","sans-serif";color:black;font-weight: bold}p.ds{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt;text-align:justify; line-height:12.65pt}span.dg{font-size:10.0pt;font-family:"Arial","sans-serif"; color:black} table.dt{margin-left:-5.4pt;border-collapse:collapse}tr.db{height:3.0pt}td.dd{width:9.8pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:3.0pt}p.du{margin:0cm;margin-bottom:.0001pt;text-autospace:none;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;font-weight: bold; margin-bottom: 6.0pt}td.dc{width:400.5pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:3.0pt}td.cz{width:9.8pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:3.0pt}p.dv{margin:0cm;margin-bottom:.0001pt;text-autospace:none;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;margin-bottom:6.0pt}td.cy{width:140.85pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:3.0pt}td.cw{width:248.85pt;border-top:none; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:3.0pt}p.dw{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:6.0pt} span.cx{font-size:10.0pt; line-height:115%;font-family:"Arial","sans-serif"}td.cv{width:9.8pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt}td.cu{width:400.5pt;border-top:none; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.ct{width:140.85pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.cs{width:248.85pt;border-top:none; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}tr.co{height:13.6pt}td.cr{width:9.8pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:13.6pt}td.cq{width:140.85pt;border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:13.6pt}td.cp{width:248.85pt;border:none; border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:13.6pt}td.cl{width:140.85pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:13.6pt} span.cn{font-size:10.0pt; line-height:115%;font-family:"Arial","sans-serif";color:black}span.cm{font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"}td.ck{width:248.85pt;border-top:none; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:13.6pt}tr.cd{height:11.55pt}td.cj{width:9.8pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:11.55pt}td.ci{width:140.85pt;border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:11.55pt}td.ch{width:4.3pt;padding:0cm 5.4pt 0cm 5.4pt; height:11.55pt}td.cg{width:103.7pt;border:none;border-bottom:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:11.55pt}td.cf{width:104.4pt;border:none;border-bottom:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:11.55pt}td.ce{width:4.05pt;border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:11.55pt} td.cc{width:4.3pt;border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:11.55pt}td.cb{width:103.7pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:11.55pt}td.ca{width:104.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:11.55pt}td.bz{width:140.85pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:11.55pt}td.by{width:4.3pt;border:none;border-bottom:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:11.55pt}td.bx{width:4.05pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:11.55pt}tr.bt{height:3.85pt}td.bw{width:9.8pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:3.85pt}td.bv{width:140.85pt;border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:3.85pt}td.bu{width:248.85pt;border:none; border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:3.85pt} td.bs{width:140.85pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:3.85pt}td.br{width:248.85pt;border-top:none; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:3.85pt}p.dx{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt; margin-left:0cm;text-align:justify;line-height:12.65pt}span.bp{font-size: 10.0pt;font-family:"Arial","sans-serif";color:black}p.dy{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt}span.dz{color: black; font-family: "Arial","sans-serif"; font-size: 10.0pt; font-weight: bold}p.ea{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left: -7.1pt;margin-bottom:.0001pt}span.eb{font-size:10.0pt; font-family:"Arial","sans-serif";color:black}table.ec{width:501.0pt;margin-left:-7.1pt;border-collapse:collapse}tr.bg{height:15.0pt} td.bj{width:254.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt}p.ed{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt}span.ee{color: black; font-family: "Arial","sans-serif"; font-size: 10.0pt; font-weight: bold}td.bh{width:225.4pt;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt}p.ef{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt}span.eg{font-size:10.0pt;font-family:"Arial","sans-serif";color:black}td.bf{width:225.4pt;padding:0cm 5.4pt 0cm 5.4pt; height:15.0pt}p.a,li.a,div.a{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";}span.bd{font-size:10.0pt;line-height:115%;font-family: "Arial","sans-serif"}p.eh{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold} span.bc{font-size:10.0pt;line-height:115%; font-family:"Arial","sans-serif"}p.ei{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:justify} /**/
RNS Number : 6335T
Cello Health PLC
21 March 2019
 

21 March 2019

 

Cello Health plc

("Cello" or the "Group")

Director/PDMR Shareholding

 

The Group provides the following notification in accordance with Article 19(3) of the Market Abuse Regulation:

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alasdair Combe

2

Reason for the notification

a)

Position/status

Person closely associated with Jane Shirley, Joint CEO of Cello Health Insight and CEO of Cello Health Europe

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Health plc

b)

LEI

2138004TZYGZLWQP7N64 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0310763

b)

Nature of the transaction

Purchase of ordinary shares

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




122.5 pence

5,000







d)

 

Aggregated information


- Aggregated volume

5,000

- Price

£6,125.00

e)

Date of the transaction

21 March 2019

f)

Place of the transaction

AIMX

 

Enquiries:

 

Cello Health plc

020 7812 8460

Mark Scott, Chief Executive


Mark Bentley, Finance Director




Cenkos Securities plc

0207 397 8900

Mark Connelly

Harry Hargreaves




 

Notes to Editors

Cello Health plc is a global healthcare-focused advisory Group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities. Cello Health plc currently services 24 of the top 25 pharmaceutical clients globally, as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.

Cello Health plc enables clients to commercialise and differentiate their assets and drive brand success in ever more complex global markets. The business delivers its services through nearly 1,000 highly skilled professionals, utilising latest thinking, technology and digital solutions.

Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York City, Philadelphia PA, London, Edinburgh, Farnham and Cheltenham.

For further information, please visit: https://cellohealthplc.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHCKDDKPBKDFNB

Quick facts: Cello Health PLC

Price: 129

Market: AIM
Market Cap: £136.91 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Cello Health reports good growth in profits and strong cash flow

Cello Health PLC's (LON:CLL) Mark Scott tells Proactive London they've seen good growth in profits and strong cash flow for the first half of the year said that he's confident about the rest of the year too. The group delivered net revenue of £54.5mln for the first six months of the year,...

on 18/9/19